Reginald Y. Gohh

TL;DR: Pre‐transplant PP may decrease the incidence of recurrent FSGS in high‐risk patients, and two patients progressed to end‐stage renal disease (ESRD) and the third has significant renal dysfunction.

TL;DR: A block-randomized, placebo-controlled, 2 2 factorial study to evaluate the potential independent effect of vitamin B6 treatment on post-methionine-loading increases in plasma homocysteine levels among clinically stable renal transplant recipients and to provide placebo- controlled confirmation of an earlier uncontrolled study showing that combined folic acid and vitamin B (12) treatment reduced fasting homocystine levels.

TL;DR: The majority of pregnancies are successful in renal transplant patients, but the risk of complications like pre-eclampsia, low birth weight and premature birth is high, and pregnancy has no significant impact on graft function or survival when baseline function is normal.

TL;DR: This is the first report showing that MRP2/ABCC2 has a crucial impact on the pharmacokinetics of tacrolimus in a haplotype-specific manner.

TL;DR: Modifiable factors, including the choice of immunosuppression, reduce the risk of acute rejection and the transplant recipient plays a substantial role in the maintenance of their allograft health through compliance with Immunosuppressive drug therapy.